Craig Tooman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Craig Tooman
Craig Tooman is recorded as CEO and CFO at Silence Therapeutics plc (SLN). The proxy statement of Silence Therapeutics plc reports total compensation of $2,246,863 for Craig Tooman in fiscal 2025, including a base salary of $690,687. Disclosed compensation is on record for 4 fiscal years. Craig Tooman has spoken on 5 earnings calls across 1 company, most recently for Silence Therapeutics plc on February 27, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
-
Start not stated–2025-12-14
-
Start not stated–2025-12-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Silence Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Iain Ross CEO, Chairman
- Rhonda Hellums CFO, Board Member
- Dave Lemus Board Member
- James Ede-Golightly Board Member
- Tim McInerney Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Silence Therapeutics plc (SLN) | Former Chief Executive Officer | $690,687 | $2,246,863 |
| 2024 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $618,844 | $3,693,970 |
| 2023 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $589,375 | $9,099,969 |
| 2022 | Silence Therapeutics plc (SLN) | Chief Executive Officer | $557,118 | $6,039,265 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.